InspireMD Inc Stock News

InspireMD, Inc. (NSPR) CEO Marvin Slosman on Q4 2021 Results - Earnings Call Transcript

InspireMD (NASDAQ: NSPR ) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM. Here''s what investors need to know about the announcement. Earnings InspireMD beat estimated earnings by 32.05%, reporting an EPS of $-0.53 versus an … Full story available on Benzinga.com

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE: BW ) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. • Desktop Metal (NYSE: DM ) is projected to report quarterly loss at $0.09 per share on revenue of $49.58 million. • Stevanato Group (NYSE: STVN ) is projected to report quarterly earnings at $0.11 per share on revenue of $244.99 million. • CPI Card (NASDAQ: PMTS ) is likely to report quarterly earnings at $0.35 per share on revenue of $94.40 million. • CareMax (NASDAQ: CMAX ) is likely to report quarterly loss at $0.06 per share on revenue of $118.44 million. • Matinas BioPharma Hldgs (AMEX: MTNB ) is expected to report quarterly loss at $0.03 per share on revenue of $470.00 thousand. • Nuvei (NASDAQ: NVEI ) is likely to report quarterly earnings at $0.57 per share on revenue of $264.56 million. • Gaotu Techedu (NYSE: GOTU ) is likely to report quarterly earnings at $0.26 per share on revenue of $333.80 million. • OptiNose (NASDAQ: OPTN ) is estimated to report quarterly loss at $0.

InspireMD (NASDAQ:NSPR) is scheduled to announce Q4 earnings results on Tuesday, March 8th, before market open.The consensus EPS Estimate is -$0.78 (-680.0% Y/Y) and the consensus…

-Earnings Conference Call to be held Tuesday, March 8, 2022, at 8:30 a.m. ET-

- Biennial Scientific Meeting of the IAGS to be held from January 31st – February 3rd 2022 - - Biennial Scientific Meeting of the IAGS to be held from January 31st – February 3rd 2022 -

It's been a shaky start to the year for markets as a hawkish Fed, and the prospect of rising rates has many advisors looking further afield for income opportunities. Strategies that have carried retir

InspireMD Inc (NSPR) shares closed 2.2% lower than its previous 52 week low, giving the company a market cap of $24M. The stock is currently down 41.5% year-to-date, down 47.5% over the past 12 months, and down 100.0% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 73.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -335.5% The company's stock price performance over the past 12 months lags the peer average by -337.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

InspireMD, Inc. (NYSEAMERICAN:NSPR) Director Paul Stuka acquired 3,177 shares of the firms stock in a transaction that occurred on Monday, November 29th. The stock was bought at an average price of $3.55 per share, for a total transaction of $11,278.35. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which []

InspireMD, Inc. (NYSEAMERICAN:NSPR) Director Paul Stuka purchased 3,177 shares of the firms stock in a transaction that occurred on Monday, November 29th. The shares were acquired at an average price of $3.55 per share, with a total value of $11,278.35. The acquisition was disclosed in a filing with the SEC, which is accessible through the []

InspireMD, Inc. (NYSEAMERICAN:NSPR) Director Paul Stuka purchased 18,328 shares of the firms stock in a transaction dated Wednesday, November 24th. The shares were bought at an average cost of $3.55 per share, for a total transaction of $65,064.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available []

InspireMD, Inc. (NYSEAMERICAN:NSPR) Director Gary S. Roubin acquired 25,930 shares of the businesss stock in a transaction on Wednesday, November 17th. The shares were purchased at an average cost of $3.86 per share, for a total transaction of $100,089.80. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is []

InspireMD, Inc. (NSPAR) CEO Marvin Slosman on Q3 2021 Results - Earnings Call Transcript

Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Right Now?